While a health care provider like a dermatologist can diagnose you with psoriasis based on a skin exam and medical history, ...

Psoriasis is one of the most common chronic inflammatory skin diseases, affecting around 250,000 people in Austria. While previous treatment approaches have mainly focused on inhibiting ...

Spiders in your home can be unnerving, but there are DIY strategies and professional solutions to get rid of them.

Do psoriasis systemic treatments raise serious infection risk? Real-world BADBIR data compares therapies and outcomes. Find ...

Background Patients with psoriasis (PsO) are at increased risk of developing psoriatic arthritis (PsA). Emerging evidence ...

Tildrakizumab delivers sustained improvements in psoriasis severity and patient-reported outcomes, according to a recent Italian study.

Generalized pustular psoriasis (GPP) is the rarest form of psoriasis, a chronic autoimmune skin condition. Unlike other forms, GPP can be severe or even life-threatening. The disease causes flares of ...

Psoriasis is more than just itchy skin that won’t cooperate. It’s a condition driven by an overactive immune response beneath the surface. “Under the skin plaques, in addition to intense inflammation, ...

For many people living with psoriasis, finding a treatment that truly works can feel life-changing — clearer skin, fewer flares, and a sense of control. But before some people can access the most ...

Almirall advances scientific leadership in medical dermatology with new data across atopic dermatitis, psoriasis, actinic keratosis and acne, reinforcing its commitment to improving patient outcomes.

"I was very ashamed. I felt like everywhere people were judging me," Amber Dean tells PEOPLE, recalling when her symptoms were at their worst Courtesy of Amber Dean (2) A woman suffered from plaque ...

Johnson & Johnson said the FDA has approved its once-daily psoriasis pill Icotyde. Icotyde targets IL-23, rivaling best-selling shots Tremfya and Skyrizi. J&J hasn't announced how much Icotyde will ...